Literature DB >> 11645779

Compliance, coercion, and compassion: moral dimensions of the return of tuberculosis.

Michael J Booker1.   

Abstract

Since 1986, we have seen a rise in the occurrence of tuberculosis in the United States. Long considered defeated in this country, the disease is returning with distressing vigor. Outbreaks of MDR-TB, tuberculosis resistant to more than one medication, have been reported around the country. This article analyzes the Centers for Disease Control and Prevention's National Action Plan to Combat Multidrug-Resistant Tuberculosis, with particular focus on the moral dimensions of mandatory directly observed treatment (DOT) and involuntary quarantine. It is proposed that a moral response to the control of tuberculosis must be one which is sustainable and which can effectively curtail the spread of the disease at a minimal cost to individual rights.

Entities:  

Keywords:  Centers for Disease Control and Prevention; Health Care and Public Health

Mesh:

Substances:

Year:  1996        PMID: 11645779     DOI: 10.1007/bf02276811

Source DB:  PubMed          Journal:  J Med Humanit        ISSN: 1041-3545


  4 in total

1.  Social, economic, and psychological impacts of MDR-TB treatment in Tijuana, Mexico: a patient's perspective.

Authors:  M D Morris; L Quezada; P Bhat; K Moser; J Smith; H Perez; R Laniado-Laborin; J Estrada-Guzman; T C Rodwell
Journal:  Int J Tuberc Lung Dis       Date:  2013-07       Impact factor: 2.373

Review 2.  Quality of Life, Psychological Interventions and Treatment Outcome in Tuberculosis Patients: The Indian Scenario.

Authors:  Vidyullatha Peddireddy
Journal:  Front Psychol       Date:  2016-10-27

3.  Critical reflections on evidence, ethics and effectiveness in the management of tuberculosis: public health and global perspectives.

Authors:  Geetika Verma; Ross E G Upshur; Elizabeth Rea; Solomon R Benatar
Journal:  BMC Med Ethics       Date:  2004-03-12       Impact factor: 2.652

4.  The concept of quarantine in history: from plague to SARS.

Authors:  Gian Franco Gensini; Magdi H Yacoub; Andrea A Conti
Journal:  J Infect       Date:  2004-11       Impact factor: 6.072

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.